Arcturus Therapeutics Holdings Inc. (ARCT): auditor change — Arcturus Therapeutics dismisses EY as auditor, appoints Deloitte; cites material weaknesses

Arcturus Therapeutics Holdings Inc.

Audit committee dismissed Ernst & Young as independent auditor effective April 5, 2024.
EY's 2023 report included an adverse opinion on internal controls over financial reporting, citing material weaknesses in ITGCs and cost review controls.
No disagreements between the company and EY on accounting principles or audit scope during fiscal years 2022 and 2023.
Deloitte & Touche appointed as new independent registered public accounting firm for fiscal year ending December 31, 2024.
Decision followed a competitive process; no prior consultations with Deloitte regarding accounting treatments.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Arcturus Therapeutics Holdings Inc. dismissed Ernst & Young LLP as its auditor.

Action: dismissal
Auditor: Ernst & Young LLP

Exact text from the filing

the audit committee of the board of directors (the " Audit Committee ") of Arcturus Therapeutics Holdings Inc.'s (the " Company " or " Arcturus ") authorized the dismissal of Ernst & Young LLP (" EY ") as the Company's independent registered public accounting firm, and EY was dismissed as the Company's independent registered public accounting firm as of such date.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Arcturus Therapeutics Holdings Inc. engaged Deloitte & Touche LLP as its auditor.

Action: engagement
Auditor: Deloitte & Touche LLP

Exact text from the filing

Effective April 5, 2024, the Audit Committee authorized the appointment of Deloitte & Touche LLP (" Deloitte ") as the Company's new independent registered public accounting firm for the fiscal year ending December 31, 2024, and Deloitte was appointed as the Company's independent registered public accounting firm.

View on SEC.gov

48 auditor changes filed in the last 30 days. Browse all auditor changes →

Arcturus Therapeutics Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001193805-24-000505

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.